Preconditioning Triggered by Carbon Monoxide (CO) Provides Neuronal Protection Following Perinatal Hypoxia-Ischemia

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Queiroga, Cláudia S F ^a,b   Tomasi, Simone ^c,d   Widerøe, Marius ^e   Alves, Paula M ^a   Vercelli, Alessandro ^c,d   Vieira, Helena L A ^a,b  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CASPASE 3; CYTOCHROME C; GLUTAMIC ACID; MESSENGER RNA; OXYGEN; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CAROTID ARTERY LIGATION; CELL MEMBRANE PERMEABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME RELEASE; EXCITOTOXICITY; FEMALE; GRANULE CELL; HIPPOCAMPUS; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; MALE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEWBORN HYPOXIA; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; CARBON MONOXIDE; CAROTID ARTERY, COMMON; CASPASE 3; CELLS, CULTURED; HIPPOCAMPUS; HYPOXIA-ISCHEMIA, BRAIN; INFLAMMATION; NECROSIS; NEURONS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

RATTUS;

EID: 84865516196     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042632     Document Type: Article

References (55)

1. Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, et al. (1999) Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res 55 (2):: 158-163.
2. Vannucci SJHH, (2004) Hypoxia-ischemia in the immature brain. J Exp Biol pp. 3149-3154.
3. Taylor RC, Cullen SP, Martin SJ, (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9 (3):: 231-241.
4. Tsujimoto Y, Nakagawa T, Shimizu S, (2006) Mitochondrial membrane permeability transition and cell death. Biochim Biophys Acta 1757 (9-10):: 1297-1300.
5. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, et al. (2007) Cell death modalities: classification and pathophysiological implications. Cell Death Differ 14 (7):: 1237-1243.
6. Carloni S, Buonocore G, Balduini W, (2008) Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol Dis 32 (3):: 329-339.
7. Kroemer G, (2003) Mitochondrial control of apoptosis: an introduction. Biochem Biophys Res Commun 304 (3):: 433-435.
8. Galluzzi L, Blomgren K, Kroemer G, (2009) Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10 (7):: 481-494.
9. Gunn AJ, Bennet L, (2008) Brain cooling for preterm infants. Clinics in perinatology 35 (4):: 735-748, vi-vii.
10. Kirino T, (2002) Ischemic tolerance. J Cereb Blood Flow Metab 22 (11):: 1283-1296.
11. Alkan T, Goren B, Vatansever E, Sarandol E, (2008) Effects of hypoxic preconditioning in antioxidant enzyme activities in hypoxic-ischemic brain damage in immature rats. Turk Neurosurg 18 (2):: 165-171.
12. Gidday JM, (2006) Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7 (6):: 437-448.
13. Dirnagl U, Becker K, Meisel A, (2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8 (4):: 398-412.
14. Dirnagl U, Meisel A, (2008) Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning? Neuropharmacology 55 (3):: 334-344.
15. Stenzel-Poore MP, Stevens SL, King JS, Simon RP, (2007) Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke 38 (2 Suppl):: 680-685.
16. Heazell AE, Froen JF, (2008) Methods of fetal movement counting and the detection of fetal compromise. J Obstet Gynaecol 28 (2):: 147-154.
17. Bonifacio SL, Glass HC, Peloquin S, Ferriero DM, (2011) A new neurological focus in neonatal intensive care. Nat Rev Neurol 7 (9):: 485-494.
18. Ahlstrom K, Biber B, Aberg A, Waldenstrom A, Ronquist G, et al. (2009) Metabolic responses in ischemic myocardium after inhalation of carbon monoxide. Acta Anaesthesiol Scand 53 (8):: 1036-1042.
19. Motterlini R, Otterbein LE, (2010) The therapeutic potential of carbon monoxide. Nature reviews 9 (9):: 728-743.
20. Biermann J, Lagreze WA, Dimitriu C, Stoykow C, Goebel U, (2012) Preconditioning with inhalative carbon monoxide protects rat retinal ganglion cells from ischemia/reperfusion injury. Investigative ophthalmology & visual science 51 (7):: 3784-3791.
21. Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, et al. (2007) Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 117 (2):: 438-447.
22. Zimmermann A, Leffler CW, Tcheranova D, Fedinec AL, Parfenova H, (2007) Cerebroprotective effects of the CO-releasing molecule CORM-A1 against seizure-induced neonatal vascular injury. Am J Physiol Heart Circ Physiol 293 (4):: H2501-2507.
23. Zeynalov E, Dore S, (2009) Low doses of carbon monoxide protect against experimental focal brain ischemia. Neurotox Res 15 (2):: 133-137.
24. Wang B, Cao W, Biswal S, Dore S, (2011) Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke 42 (9):: 2605-2610.
25. Vieira HL, Queiroga CS, Alves PM, (2008) Preconditioning induced by carbon monoxide provides neuronal protection against apoptosis. J Neurochem 107 (2):: 375-384.
26. Queiroga CS, Almeida AS, Martel C, Brenner C, Alves PM, et al. (2010) Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis. J Biol Chem 285 (22):: 17077-17088.
27. Schousboe I, Larsson OM, Schousboe A, (1989) Development of homospecific activity of GABA-transaminase in the mouse cerebral cortex and cerebellum and in neurons cultured from these brain areas. Int J Dev Neurosci 7 (1):: 115-121.
28. Zuckerbraun BS, Billiar TR, Otterbein SL, Kim PK, Liu F, et al. (2003) Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med 198 (11):: 1707-1716.
29. Otterbein LE, May A, Chin BY, (2005) Carbon monoxide increases macrophage bacterial clearance through Toll-like receptor (TLR)4 expression. Cell Mol Biol (Noisy-le-grand) 51 (5):: 433-440.
30. Nakao A, Kaczorowski DJ, Wang Y, Cardinal JS, Buchholz BM, et al. (2010) Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant 29 (5):: 544-553.
31. Rice JE 3rd, Vannucci RC, Brierley JB, (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Annals of neurology 9 (2):: 131-141.
32. Levine S, (1960) Anoxic-ischemic encephalopathy in rats. Am J Pathol 36: 1-17.
33. Vannucci RC, Vannucci SJ, (1997) A model of perinatal hypoxic-ischemic brain damage. Ann N Y Acad Sci 835: 234-249.
34. Wideroe M, Olsen O, Pedersen TB, Goa PE, Kavelaars A, et al. (2009) Manganese-enhanced magnetic resonance imaging of hypoxic-ischemic brain injury in the neonatal rat. Neuroimage 45 (3):: 880-890.
35. Almeida SS, Queiroga CS, Sousa MF, Alves PM, Vieira HL, (2012) Carbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astrocytes: role of BCL-2. J Biol Chem 287 (14):: 10761-10770.
36. Fitting S, Booze RM, Hasselrot U, Mactutus CF, (2008) Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study. Hippocampus 18 (2):: 135-147.
37. Shapiro SS, Wilk MB, (1965) An analysis of variance test for normality (complete samples). Biometrika 52: 591-611.
38. Levene H, (1960) Robust tests for equality of variances. Stanford University Press pp. 278-292.
39. Hagberg H, (2004) Mitochondrial impairment in the developing brain after hypoxia-ischemia. J Bioenerg Biomembr 36 (4):: 369-373.
40. Ge W, Chen YW, Weng R, Lim SF, Buescher M, et al. (2011) Overlapping functions of microRNAs in control of apoptosis during Drosophila embryogenesis. Cell Death Differ.
41. Ness JM, Harvey CA, Strasser A, Bouillet P, Klocke BJ, et al. (2006) Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Res 1099 (1):: 150-159.
42. Queiroga CS, Almeida AS, Alves PM, Brenner C, Vieira HL, (2011) Carbon monoxide prevents hepatic mitochondrial membrane permeabilization. BMC cell biology 12: 10.
43. Ahmad AS, Zhuang H, Dore S, (2006) Heme oxygenase-1 protects brain from acute excitotoxicity. Neuroscience 141 (4):: 1703-1708.
44. Arpino C, D'Argenzio L, Ticconi C, Di Paolo A, Stellin V, et al. (2005) Brain damage in preterm infants: etiological pathways. Annali dell'Istituto superiore di sanita 41 (2):: 229-237.
45. Ara J, Fekete S, Frank M, Golden JA, Pleasure D, et al. (2011) Hypoxic-preconditioning induces neuroprotection against hypoxia-ischemia in newborn piglet brain. Neurobiol Dis 43 (2):: 473-485.
46. McAuliffe JJ, Joseph B, Vorhees CV, (2007) Isoflurane-delayed preconditioning reduces immediate mortality and improves striatal function in adult mice after neonatal hypoxia-ischemia. Anesthesia and analgesia 104 (5):: 1066-1077, tables of contents.
47. Cai J, Kang Z, Liu WW, Luo X, Qiang S, et al. (2008) Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett 441 (2):: 167-172.
48. Li Q, Li H, Roughton K, Wang X, Kroemer G, et al. (2010) Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell death & disease 1: e56.
49. Robinson BR, Athota KP, Branson RD, (2009) Inhalational therapies for the ICU. Current opinion in critical care 15 (1):: 1-9.
50. Bloch KD, Ichinose F, Roberts JD Jr, Zapol WM, (2007) Inhaled NO as a therapeutic agent. Cardiovasc Res 75 (2):: 339-348.
51. Sanders RD, Ma D, Maze M, (2004) Xenon: elemental anaesthesia in clinical practice. British medical bulletin 71: 115-135.
52. Ryang YM, Fahlenkamp AV, Rossaint R, Wesp D, Loetscher PD, et al. (2011) Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Critical care medicine 39 (6):: 1448-1453.
53. Motterlini R, (2007) Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans 35 (Pt 5):: 1142-1146.
54. Stein AB, Bolli R, Dawn B, Sanganalmath SK, Zhu Y, et al. (2012) Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. J Mol Cell Cardiol 52 (1):: 228-236.
55. Yabluchanskiy A, Sawle P, Homer-Vanniasinkam S, Green CJ, Foresti R, et al. (2012) CORM-3, a carbon monoxide-releasing molecule, alters the inflammatory response and reduces brain damage in a rat model of hemorrhagic stroke*. Critical care medicine 40 (2):: 544-552.